Carole Huntsman is North America Head of Multiple Sclerosis, Oncology and Immunology for Sanofi Genzyme, the specialty care global business unit of Sanofi. In this role, she is focused on driving the U.S. launches of Dupixent and Kevzara, expanding Sanofi Genzyme’s leadership in Multiple Sclerosis, and reestablishing growth in the Oncology business.
Carole joined Sanofi Genzyme in 2012 as Vice President and Multiple Sclerosis Business Unit Head, North America, and led the successful launches of both Aubagio and Lemtrada. Most recently, Carole served as Global Lead, Multiple Sclerosis, with responsibility for the strategic planning and direction for the MS brands in markets globally.
Before joining Sanofi Genzyme, Carole was Senior Vice President, Neurodegenerative Diseases and Rheumatology at EMD Serono. In her over 25 years of pharmaceutical and biotech experience, she has also worked at Pfizer, Inc. and Muro Pharmaceuticals, an ASTA Medica company. Additionally, Carole was commissioned as an officer in the U.S. Army, spending four years on active duty and more than twelve years in the Army Reserves.
Carole earned her Master’s in Business Administration with a concentration in Marketing and Consulting from Boston College – Wallace E. Carroll Graduate School of Management and her Bachelor of Arts in History from Boston College.